These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37435703)

  • 1. Equity, diversity, and inclusion in global cancer clinical trial authorship.
    Eldridge L; Ginsburg O; Gopal S; Odeny TA
    Cancer; 2023 Sep; 129(18):2771-2772. PubMed ID: 37435703
    [No Abstract]   [Full Text] [Related]  

  • 2. The measurable impact of a diversity, equity, and inclusion editor on diversifying content, authorship, and peer review participation in the Journal of Vascular Surgery.
    Weaver ML; Sorber RA; Holscher CM; Cox ML; Henry BV; Brooke BS; Cooper MA
    J Vasc Surg; 2023 Feb; 77(2):330-337. PubMed ID: 36368645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity, Equity, Inclusion, and Accessibility in Cancer Care: A Synopsis of Literature From 2021 Through April 2023.
    Boyle DA
    Clin J Oncol Nurs; 2023 May; 27(3):323-342. PubMed ID: 37267499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).
    Pothuri B; Blank SV; Myers TK; Hines JF; Randall LM; O'Cearbhaill RE; Slomovitz BM; Eskander RN; Alvarez Secord A; Coleman RL; Walker JL; Monk BJ; Moore KN; O'Malley DM; Copeland LJ; Herzog TJ
    Gynecol Oncol; 2023 Jul; 174():278-287. PubMed ID: 37315373
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment.
    Guerra C; Pressman A; Hurley P; Garrett-Mayer E; Bruinooge SS; Howson A; Kaltenbaugh M; Hanley Williams J; Boehmer L; Bernick LA; Byatt L; Charlot M; Crews J; Fashoyin-Aje L; McCaskill-Stevens W; Merrill J; Nowakowski G; Patel MI; Ramirez A; Zwicker V; Oyer RA; Pierce LJ
    JCO Oncol Pract; 2023 Apr; 19(4):e581-e588. PubMed ID: 36630663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor.
    Versavel S; Subasinghe A; Johnson K; Golonski N; Muhlhausen J; Perry P; Sanchez R
    Contemp Clin Trials; 2023 Mar; 126():107092. PubMed ID: 36702295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research: DRIVE.
    Birhiray MN; Birhiray RE
    Blood Adv; 2023 Apr; 7(8):1507-1512. PubMed ID: 36005840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to Cultivate Diversity and Achieve Equity in Cardiovascular Clinical Trials.
    Dixon DD; Wilkins CH
    Circulation; 2023 Jul; 148(3):204-206. PubMed ID: 37459412
    [No Abstract]   [Full Text] [Related]  

  • 9. Why Diverse Clinical Trial Participation Matters.
    Schwartz AL; Alsan M; Morris AA; Halpern SD
    N Engl J Med; 2023 Apr; 388(14):1252-1254. PubMed ID: 37017480
    [No Abstract]   [Full Text] [Related]  

  • 10. Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot.
    Matthew-Onabanjo AN; Nortey G; Matulewicz RS; Basak R; Culton DA; Weaver KN; Gallagher KK; Tan HJ; Rose TL; Milowsky M; Bjurlin MA
    Curr Probl Cancer; 2023 Jun; 47(3):100958. PubMed ID: 37084464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authorship diversity in global evidence synthesis in urology: 1998-2022 analysis of Cochrane reviews.
    Ozair A; Kumar A; Subash NR; Mirza S; Khosla AA; Ahluwalia M; Dahm P
    BJU Int; 2023 Jul; 132(1):34-36. PubMed ID: 36951507
    [No Abstract]   [Full Text] [Related]  

  • 12. Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers.
    Lawrence DS; Leeme T; Mosepele M; Harrison TS; Seeley J; Jarvis JN
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009376. PubMed ID: 34043617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.
    McNamara MG; Bridgewater J; Goyal L; Jacobs T; Wagner AD; Goldstein D; Shroff R; Moehler M; Lowery M; Bekaii-Saab T; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox J; Valle J
    BMJ Open; 2022 Oct; 12(10):e064954. PubMed ID: 36288834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990-2013.
    Kelaher M; Ng L; Knight K; Rahadi A
    Int J Epidemiol; 2016 Dec; 45(6):2174-2183. PubMed ID: 28199646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity, Equity, and Inclusion: A Decade of Progress?
    Jones BL; Carter MC; Davis CM; Wang J
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):116-125. PubMed ID: 36272720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Trends for Diversity, Equity, and Inclusion Among Medical Faculty and Clinical Trial Participation.
    Alcorn SR; Chino F
    Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):207-211. PubMed ID: 37179079
    [No Abstract]   [Full Text] [Related]  

  • 17. Author declaration: have you considered equity, diversity and inclusion?
    Rößler DC; Lötters S; Da Fonte LFM
    Nature; 2020 Aug; 584(7822):525. PubMed ID: 32814917
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of accountability in upholding authorship standards in prominent medical oncology clinical trials.
    Gui DY; Weiss GJ
    Curr Oncol; 2019 Oct; 26(5):e693-e695. PubMed ID: 31708662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honorary and ghost authorship in reports of randomised clinical trials in oncology.
    Vera-Badillo FE; Napoleone M; Krzyzanowska MK; Alibhai SM; Chan AW; Ocana A; Templeton AJ; Seruga B; Amir E; Tannock IF
    Eur J Cancer; 2016 Oct; 66():1-8. PubMed ID: 27500368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leadership for change: working toward equity, diversity, and inclusion.
    Bryan J; Johnson K; Ali H; McIlveen-Brown E; Kernick A; Primavesi R; Kitty D; LeBlanc C
    CJEM; 2023 Apr; 25(4):278-281. PubMed ID: 36719621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.